X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

U.S. In Vitro Diagnostics (IVD) Market by Technology , Application , End User & by Region – Forecast to 2020

Yuvraj_pawp by Yuvraj_pawp
18th March 2016
in Insights

Report DescriptionTable of ContentSummaryRequest Sample

The U.S. IVD market is projected to reach USD 25.99 Billion by 2020 at a CAGR of 4.7% during the forecast period of 2015 to 2020. Some of the key factors driving the growth of this market are the rising incidence of chronic and infectious diseases in the U.S., rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing adoption of automated instruments, and automation in laboratories. The extending reach of molecular diagnostics and new range of condition-specific markers and tests with advances in genomics and proteomics are creating new opportunities for this market. However, the unfavorable reimbursement and lack of sufficient budget is hampering the growth of the U.S. IVD industry. Stringent regulatory framework presents a significant challenge to the market growth.

Over the past few years, the U.S. in vitro diagnostics market has witnessed steady growth owing to the increasing demand for high-performance products. Increasing urbanization and changing lifestyles have resulted in the growing incidence of chronic ailments such as diabetes, blood pressure, and cardiovascular diseases. This is further fueling the demand of innovative in-vitro diagnostic products for the early detection and diagnosis of these diseases. As a result, currently, most of the leading players in the in vitro diagnostics market are focusing on acquisitions as a major strategy to capture market share and sustain their leadership position in this market. Acquisition of similar or smaller players has enabled these companies to achieve greater competitiveness through the expansion of their product portfolio and technological expertise in a short period of time.

Geographically, the U.S. is the largest regional segment of the global IVD market. The large share of this region can be attributed to the accessibility to technologies, superlative opportunities for molecular diagnostics in genetic testing and cancer screening, established distribution channels, and the presence of a large number of market players such as Abbott Laboratories, Inc., Johnson & Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., and Alere, Inc. Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Siemens Healthcare (Germany), Thermo Fisher Scientific Inc. (U.S.), and Abbott Laboratories, Inc. (U.S.) are the leading companies, which accounted for ~50-55% of the market in 2014. However, new local players are intensifying competition and thereby threatening the market share of existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market, thereby driving market growth.

To know about the assumptions considered for the study, download the pdf brochure

Stakeholders of the Report:

  • IVD Product Manufacturers
  • Group Purchase Organizations (GPOs)
  • OEM Manufacturers
  • Clinical Laboratories
  • Distributors of IVD Products
  • Hospitals and Clinics
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
  • Scope of the Report


This research report categorizes the U.S. IVD market on the basis of products & services, technologies, applications, and end users. These markets are further segmented, providing value analysis for 2013, 2014, and 2015, as well as forecast up to 2020. The end user market is comprehensively analyzed by region (South, Midwest, West, and Northeast) to provide in-depth information on the U.S. scenario.

U.S. In Vitro Diagnostics Market

This research report categorizes the U.S. in-vitro diagnostics market into the following segments:

U.S. In Vitro Diagnostics Market, by Products & Services

  • Reagents
  • Instrument
  • Fully Automated Instruments
  • Semi-automated Instruments
  • Others


Data Management Systems/Software

Services
U.S. In Vitro Diagnostics Market, by Technology

  • Clinical Chemistry
  • Immunochemistry/Immunoassay
  • Hematology
  • Coagulation & Hemostasis
  • Microbiology
  • Molecular Diagnostics (MDx)
  • Other Instruments


U.S. In Vitro Diagnostics Market, by Application

  • Infectious Diseases
  • Diabetes
  • Oncology/Cancer
  • Cardiology
  • Endocrine Disorders
  • Autoimmune Diseases
  • Bone & Mineral Disorders
  • Pulmonary Disorders
  • Others


U.S. In Vitro Diagnostics Market, by End User

  • Hospital Laboratories
  • Clinical/Independent Laboratories
  • Large Laboratories
  • Medium-sized Laboratories
  • Small Laboratories
  • Others


U.S. In Vitro Diagnostics End User Market, by Region

  • Hospital Laboratories Market
  • South
  • Midwest
  • West
  • Northeast


Clinical/Independent Laboratories

  • South
  • Midwest
  • West
  • Northeast
  • Others

Previous Post

Acrylic Acid Market by Derivative (Esters/Acrylates - METHYL, ETHYL, BUTYL, 2-EH; Polymers - Elastomers, Superabsorbent Polymers, Water Treatment Polymers; Other Derivatives), by Applications & Region - Global Forecast to 2020

Next Post

Terahertz and Infrared Spectroscopy Market by Spectrum , by Technology , by Application - Global Forecasts to 2020

Related Posts

Capsules Market
Insights

Empty Capsules Market Growth to Reach $4.2B by 2029

16th April 2025
Omics Based Clinical Trials
Asia

Asia Pacific Omics-Based Clinical Trials Market Growth

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Insights

Biopharmaceutical Manufacturing With Continuous Processing

21st March 2025
Insights

CDMO Growth and Biotechnology Outsourcing Trends

7th March 2025
Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Next Post

Terahertz and Infrared Spectroscopy Market by Spectrum , by Technology , by Application - Global Forecasts to 2020

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In